<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00701480</url>
  </required_header>
  <id_info>
    <org_study_id>MTU-E-1-002/51</org_study_id>
    <nct_id>NCT00701480</nct_id>
  </id_info>
  <brief_title>Safety and Efficacy of Skin Cleanser Contained Roselle Extract in Acne</brief_title>
  <official_title>Randomized Double-Blind Case Control Study of Safety and Efficacy of Skin Cleanser Contained Hibiscus Sabdariffa Extract in Acne Treatment.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Thammasat University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Research Council of Thailand</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Thammasat University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Skin cleanser for daily used is essential and one of the most common questions asked by acne
      patients. There are studies reported beneficial effects of cleansers in acne treatment.
      Extracts of plants as active ingredients in skin cleansers are increasingly popular
      worldwide. Roselle is a common tropical shrub. Usually, the calyces of the plant have been
      used to make beverages but it also used in Thai traditional medicine for several purposes
      including as antiseptic and astringent. The extract of roselle showed antioxidant and
      keratolytic effects from previous studies which fit to the pathogenesis of acne. The aims of
      the study is to determine the safety and efficacy of skin cleanser contained roselle extract
      in acne.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Acne is one of the most common skin problems in teenagers and adolescents. Keys pathogenesis
      of the disease are 1.abnormal hypercornification of pilosebaceous duct,2.excess sebum
      production, 3.inflammation, 4.the present of Propionibacterium acnes. Treatments often
      include combination of topical and oral medications according to degree of acne severities.
      Acne medications can lead to drying and irritation of skin. Proper skin cleansing is
      important and can improve tolerability and efficacy of acne treatment.

      Traditional medicine with longstanding used of herbal ingredients for skin problems and
      beauty is increasing more popular. Hibiscus sabdariffa L.(Roselle) is used as food, drink and
      topical formulation for skin infection in Thai traditional medicine. The extract from calyces
      contained polyphenolic compounds and anthocyanins that showed antioxidant and keratolytic
      activities. There for skin cleanser with Roselle extract might be benefit to acne by loosen
      comedone, reduce Propionibacterium acne and prevent keratinocyte injury.

      The purposes of this study is to evaluate skin cleanser contained Roselle extract in two
      aspects ; 1. safety for irritation and allergic effects, 2. efficacy in acne as cleanser
      alone and as supportive care with others acne therapies.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>April 2008</start_date>
  <completion_date type="Anticipated">September 2008</completion_date>
  <primary_completion_date type="Anticipated">July 2008</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>1. Safety evaluation: Patch test 2. Efficacy evaluation: Acne lesions counts/ acne severity grading</measure>
    <time_frame>6 weeks</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>1. Safety evaluation: &quot;a.&quot; Skin properties by visual and tactile features., &quot;b.&quot; Biophysical parameters of skin. 2.Efficacy evaluation: Patient assessments.</measure>
    <time_frame>6 weeks</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Acne</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>skin cleanser contained Hibiscus sabdariffa</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>marketed skin cleanser</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>skin cleanser contained Hibiscus sabdariffa extract</intervention_name>
    <description>face washing 2-3 times/day</description>
    <arm_group_label>1</arm_group_label>
    <other_name>Roselle skin cleanser</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>marketed skin cleanser</intervention_name>
    <description>face washing 2-3 times/day</description>
    <arm_group_label>2</arm_group_label>
    <other_name>Clean and Clear</other_name>
    <other_name>Clearasil</other_name>
    <other_name>Neutrogena</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  age 12-45 yrs,both sex

          -  clinical diagnosis of mild to moderately severe acne vulgaris(grade 1-3)

          -  have at least 10 facial acne lesions

          -  not changing any acne treatment during study period

          -  able to follow up according to protocol

          -  Written informed consent

        Exclusion Criteria:

          -  pregnant or breast feeding

          -  severe acne(grade4 or nodulocystic acne)

          -  treated with isotretinoin orally during the last 3 months

          -  have other systemic disease or illness

          -  have allergic history to Roselle
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>12 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mali - Achariyakul, MD.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Thammasat University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Mali - Achariyakul, MD.</last_name>
    <phone>66-02-9269473</phone>
    <email>mali1799@hotmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Narumol - Teeranulak, MD.</last_name>
    <phone>66-02-9269474</phone>
    <email>narumol-the@yahoo.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Thammasat University</name>
      <address>
        <city>KlongLaung</city>
        <state>Pathumtanee</state>
        <zip>12120</zip>
        <country>Thailand</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mali - Achariyakul, MD.</last_name>
      <phone>66-02-9269473</phone>
      <email>mali1799@hotmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Narumon Teeranurak, MD.</last_name>
      <phone>66-02-9269474</phone>
    </contact_backup>
    <investigator>
      <last_name>Narumon - Teeranurak, MD.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Vareeporn - Dispanurat, MD.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Thailand</country>
  </location_countries>
  <verification_date>June 2008</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 17, 2008</study_first_submitted>
  <study_first_submitted_qc>June 17, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 19, 2008</study_first_posted>
  <last_update_submitted>June 17, 2008</last_update_submitted>
  <last_update_submitted_qc>June 17, 2008</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 19, 2008</last_update_posted>
  <responsible_party>
    <name_title>Mali Achariyakul/Dr.</name_title>
    <organization>Thammasat University</organization>
  </responsible_party>
  <keyword>acne</keyword>
  <keyword>skin cleanser</keyword>
  <keyword>Hibiscus sabdariffa</keyword>
  <keyword>Roselle</keyword>
  <keyword>safety</keyword>
  <keyword>efficacy</keyword>
  <pending_results>
    <submitted>November 20, 2008</submitted>
    <returned>December 18, 2008</returned>
  </pending_results>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

